Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to $5.3 billion.

  • Novartis Ag's Other Non-Current Assets rose 5049.93% to $5.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 billion, marking a year-over-year increase of 5049.93%. This contributed to the annual value of $5.3 billion for FY2025, which is 5049.93% up from last year.
  • As of Q4 2025, Novartis Ag's Other Non-Current Assets stood at $5.3 billion, which was up 5049.93% from $4.8 billion recorded in Q3 2025.
  • Novartis Ag's 5-year Other Non-Current Assets high stood at $5.3 billion for Q4 2025, and its period low was $1.1 billion during Q3 2023.
  • Its 5-year average for Other Non-Current Assets is $2.6 billion, with a median of $2.2 billion in 2021.
  • Per our database at Business Quant, Novartis Ag's Other Non-Current Assets crashed by 6890.6% in 2023 and then soared by 24434.85% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Other Non-Current Assets stood at $2.2 billion in 2021, then plummeted by 49.77% to $1.1 billion in 2022, then increased by 8.02% to $1.2 billion in 2023, then skyrocketed by 192.33% to $3.5 billion in 2024, then surged by 50.5% to $5.3 billion in 2025.
  • Its Other Non-Current Assets was $5.3 billion in Q4 2025, compared to $4.8 billion in Q3 2025 and $4.5 billion in Q2 2025.